Introduction
Prostate Cancer Research is a UK medical research charity that funds innovative scientific projects, supports researchers, provides patient information and works to improve the diagnosis, treatment and survival of people affected by prostate cancer.
History and Background
Prostate Cancer Research was founded in 1988 by Professor John Masters, a scientist committed to developing better treatments for prostate cancer.
The organisation was originally known as the Prostate Cancer Research Centre. It was established to help promising scientists develop the evidence and experience needed to secure funding from larger research organisations.
The charity subsequently expanded its research portfolio, public engagement and patient involvement. It now works across laboratory science, treatment development, health data, patient information, translational research and healthcare policy.
Prostate Cancer Research is registered as a charity in England and Wales under charity number 1156027. Its legal charitable purpose includes promoting medical and scientific research into the causes and treatment of cancer and related diseases and sharing useful research findings.
Mission and Purpose
Prostate Cancer Research works toward a world free from the impact of prostate cancer.
Its central mission is to fund research that increases survival, develops better treatments and ultimately finds a cure, particularly for advanced prostate cancer.
The charity supports research across the scientific pathway, from early biological discoveries to projects that could produce new drugs, diagnostic methods or treatment strategies.
Its purpose extends beyond laboratory research. Prostate Cancer Research also seeks to ensure that scientific discoveries reach patients, healthcare inequalities are addressed and people affected by the disease participate in shaping research priorities.
The organisation’s principal focus areas include understanding prostate cancer biology, preventing cancer progression, overcoming treatment resistance, developing new therapies, improving personalised treatment, advancing early diagnosis, reducing health inequalities and translating scientific discoveries into patient care.
Governance and Organisational Structure
Prostate Cancer Research is governed by a Board of Trustees responsible for protecting the charity’s mission, overseeing its finances and ensuring compliance with charity law.
The trustees approve organisational strategy, assess risk, monitor performance and ensure that charitable resources are used appropriately.
A senior leadership team manages the charity’s daily operations. Its responsibilities include research funding, patient engagement, communications, fundraising, finance, partnerships and policy work.
Scientific experts also play an important role in the organisation’s governance. Research proposals are assessed through independent scientific peer review before funding decisions are made.
The charity is a member of the Association of Medical Research Charities and follows its principles of peer review. This helps ensure that funding decisions are independent, transparent and based on scientific quality, potential impact and relevance to patients.
Patients and members of the public also contribute to research assessment. Proposals include plain-language summaries so that people without specialist scientific knowledge can understand and evaluate the proposed work.
Funding Mechanisms
Prostate Cancer Research raises funds through individual donations, regular giving, fundraising events, corporate partnerships, gifts in wills, memorial donations, charitable trusts and foundations.
Supporters can organise fundraising activities, participate in sponsored events, make one-time or recurring donations, purchase items from the charity’s shop or include a charitable gift in their estate planning.
Corporate partnerships provide financial support while creating opportunities for employee engagement, awareness campaigns and collaborative fundraising.
The charity may also fund research jointly with other medical research organisations. Co-funded awards allow organisations to combine expertise and financial resources around projects with strong scientific potential.
Annual accounts are published to explain how the charity raises and spends money in support of its mission. Financial information and annual returns are also available through the Charity Commission for England and Wales.
Research Grants
Prostate Cancer Research awards funding to qualified scientists and research teams working on prostate cancer.
Its portfolio includes projects based at universities, hospitals, medical schools and specialist cancer research institutions. Funding supports research from early-stage scientific investigation through to drug development and clinical translation.
Applications undergo scientific peer review. Independent experts examine the quality of the science, the research methodology, the experience of the applicants and the potential contribution to prostate cancer treatment or care.
A Scientific Committee reviews applications and monitors funded projects. Researchers are expected to submit progress reports and demonstrate that grant funding is being used for the approved purposes.
Funding opportunities are generally intended for eligible researchers and research institutions rather than individual patients, community organisations or general nonprofit applicants.
Research Strategy
The research strategy is based on scientific excellence, innovation, collaboration, career development and patient benefit.
The charity actively looks for ambitious research ideas that could transform how prostate cancer is understood or treated.
It supports collaboration between laboratories, universities, healthcare institutions, patients and other research funders. Collaborative research can combine different scientific disciplines and accelerate the movement of discoveries toward clinical application.
Developing the next generation of prostate cancer researchers is another important priority. The charity supports early-career scientists and encourages talented researchers to establish long-term careers in the field.
Research accessibility is also considered. Prostate Cancer Research encourages work that could reduce the long-term cost and burden of treatment for patients, families and healthcare systems.
Major Research Areas
Prostate Cancer Research funds studies examining why prostate cancer develops, how it spreads and why some tumours become resistant to treatment.
Projects investigate genetic changes, tumour biology, immune responses, cell communication and the environment surrounding cancer cells.
Researchers also study why hormone therapies eventually stop working for some patients and how resistant cancers could be targeted through new treatment combinations.
Other projects examine DNA damage and repair mechanisms. Identifying weaknesses in the way prostate cancer cells repair damaged DNA may create opportunities for more precise treatments.
The organisation supports studies of metastatic prostate cancer, which occurs when cancer spreads to other parts of the body. Advanced and metastatic disease remains a major research priority because it is responsible for most prostate cancer deaths.
Translational Research and Proven Connect
Translational research is the process of moving scientific discoveries from laboratories toward practical treatments and patient care.
Prostate Cancer Research supports this process through Proven Connect, a platform focused on accelerating promising prostate cancer innovations.
The initiative helps connect scientists, patients, industry specialists, investors and other stakeholders who can advance research toward clinical use.
This approach addresses the gap that often exists between making a laboratory discovery and developing it into a medicine, diagnostic test or treatment available within healthcare systems.
By supporting research translation, the charity seeks to ensure that promising discoveries do not remain limited to academic publications.
Early-Career Research Support
Prostate Cancer Research supports scientists at the beginning of their independent research careers.
Its Early Career Fellowship in Prostate Cancer Research is designed to help talented researchers develop expertise, generate evidence and establish independent research programs.
Supporting early-career scientists helps build long-term research capacity. It also brings new perspectives, technologies and approaches into prostate cancer research.
Career-development funding can provide salary support, research expenses, mentoring and opportunities to work within established scientific institutions.
Prostate Progress
Prostate Progress is a major research initiative that combines NHS health information with the lived experiences of people affected by prostate cancer.
The program is designed to help researchers understand how prostate cancer develops, how treatments perform in real-world settings and how the disease affects quality of life.
Participants can contribute health data and information about their experiences. Bringing these sources together creates a more detailed picture of diagnosis, treatment, side effects and long-term outcomes.
In 2026, the NHS announced plans to invite 500,000 men to participate in the research program. This large-scale participation has the potential to strengthen future studies and improve prostate cancer care.
The initiative also demonstrates the charity’s commitment to patient-powered research, in which people affected by the disease contribute directly to scientific progress.
Patient Information and the Infopool
Prostate Cancer Research provides accessible information to help patients and families understand testing, diagnosis, treatment, side effects and life after prostate cancer.
The Infopool is the charity’s dedicated patient-information platform. It brings together clear information, treatment experiences and practical resources.
Patients can learn about different treatment options and consider questions they may wish to discuss with healthcare professionals.
The platform also includes lived experiences from people affected by prostate cancer. These accounts can help patients understand how treatments and side effects may affect individuals differently.
Patient information is intended to support informed conversations with qualified healthcare professionals rather than replace personalised medical advice.
Patient and Public Involvement
The charity works to ensure that research reflects the priorities and experiences of people affected by prostate cancer.
Patients contribute to proposal assessment, research design, public communication and the identification of important research questions.
Researchers are required to explain their projects in everyday language, making the proposed work understandable to patients and non-specialist reviewers.
This approach can improve the relevance of funded studies and help scientists consider quality of life, treatment burden, access and other issues that matter to patients.
Addressing Health Inequalities
Prostate Cancer Research works to address inequalities in diagnosis, treatment and research participation.
Black men have a substantially higher risk of developing prostate cancer than the general male population. However, Black communities have historically been underrepresented in health research and clinical studies.
The charity develops research and engagement initiatives intended to improve understanding, participation and trust among underserved communities.
It also brings together patients, community representatives, researchers and healthcare organisations to identify barriers involving awareness, testing, diagnosis and access to treatment.
Closing these gaps is important because medical progress cannot produce equitable outcomes if some communities remain excluded from research or healthcare services.
Healthcare Policy and Advocacy
Prostate Cancer Research works to influence healthcare policy and improve access to advances in diagnosis and treatment.
The charity communicates with policymakers, responds to developments in prostate cancer screening and encourages supporters to contact elected representatives.
Its policy work is informed by research evidence and the experiences of patients and families.
The organisation seeks to ensure that scientific advances are translated into healthcare practice and made accessible to people who may benefit from them.
Impact and Examples of Funded Research
Prostate Cancer Research funds a diverse portfolio of projects at leading UK institutions, including universities and specialist cancer research centres.
One funded project at Cardiff University received approximately £491,731 over three years to investigate Wnt signalling as a possible treatment target for metastatic prostate cancer.
Another project, co-funded with Worldwide Cancer Research, received support of approximately £155,000 per year to examine DNA damage and identify vulnerabilities that could be targeted in prostate cancer cells.
The charity has also supported research investigating how prostate tumours communicate with surrounding fat tissue and whether this relationship contributes to aggressive disease.
Other funded teams study hormone-treatment resistance, tumour metabolism, immune responses, cancer spread and potential new therapeutic targets.
The organisation’s impact is not limited to individual discoveries. It also develops scientific careers, connects researchers with patients and helps promising innovations progress toward practical application.
Fundraising and Public Support
Public donations are central to the organisation’s ability to fund research.
Supporters can participate in walks, runs and other sponsored activities. They may also establish personal fundraising campaigns or organise community events.
Gifts in wills provide long-term support for scientific research. Memorial giving allows families and friends to honour someone’s life while contributing to future treatments.
Business partnerships can include corporate donations, employee fundraising, sponsorship and awareness initiatives.
Every funding source helps the charity maintain existing research projects and invest in new scientific ideas.
Transparency and Accountability
Prostate Cancer Research publishes annual accounts showing how it raises and uses charitable funds.
Its activities and finances are subject to independent examination or audit and regulatory reporting requirements.
Scientific grants are awarded through peer review and monitored throughout the funding period. Researchers must report on progress, expenditure and scientific outputs.
The charity also publishes details of its research portfolio so supporters and patients can understand the projects being funded.
These governance and reporting processes help protect scientific independence and maintain public confidence.
Why Prostate Cancer Research Matters
Prostate cancer can range from slow-growing disease requiring careful monitoring to aggressive cancer that spreads rapidly and becomes resistant to treatment.
Although treatment has improved, advanced prostate cancer remains difficult to cure. More research is needed to understand tumour biology, detect aggressive cancers earlier and develop treatments that continue working after existing therapies fail.
Specialist research charities help address this need by supporting ideas that may be too early, ambitious or specialised for conventional funding sources.
Prostate Cancer Research also connects scientific discovery with patient experience, ensuring that research remains focused on meaningful improvements in survival, treatment and quality of life.
Conclusion
Prostate Cancer Research is a UK medical research charity dedicated to improving survival and developing better treatments for prostate cancer.
Since its establishment in 1988, the organisation has expanded from supporting individual scientists to funding a diverse research portfolio covering cancer biology, treatment resistance, metastatic disease, drug development, health data and translational research.
Its grants, early-career support, Proven Connect platform, Infopool and Prostate Progress initiative connect scientific research with patient experience and healthcare improvement.
Through donations, partnerships, rigorous peer review and collaboration with leading institutions, Prostate Cancer Research works to accelerate progress toward a future in which prostate cancer no longer limits or ends lives.
For more information, visit here.
